Skip to main content
News Icon

News categories: Honors & Funding

Focus Funding for research on COVID-19

Focus funding on coronavirus

The German Research Foundation (DFG) is funding 33 research projects on infection with SARS-CoV-2 with a total of 3.6 million euros for a maximum of one year. A team from the Cluster of Excellence ImmunoSensation receives this new type of focus funding on COVID-19.

Christian Bode from the Clinic for Anaesthesiology and Operative Intensive Care Medicine and Christoph Wilhelm from the Institute for Clinical Chemistry and Clinical Pharmacology and the Cluster of Excellence ImmunoSensation2 at the University of Bonn are now supported with the project "The role of ketogenesis in the immune response against SARS-CoV-2" as part of the focus funding. It is about whether and how the immune system remains fully functional against the novel corona virus even during a reduced food intake in COVID-19.

Related news

News Icon

News categories: Honors & Funding

Otto-Westphal Thesis Prize for Jonas Schulte-Schrepping

The German Society for Immunology e.V. (DGfI) anually honours one of its members by awarding the Otto-Westphal Thesis Prize. This year, Jonas Schulte-Schrepping from the research group of Prof. Joachim Schultze at the DZNE was selected for his PhD thesis on the systemic immune response to COVID-19. The prize is endowed with a prize money of 1,500 EUR.
View entry
DGORH Honours

News categories: Honors & Funding

Honours for research orthopaedic rheumatology

The German Society for Orthopaedic Rheumatology (DGORh) awards the Arthur Vick Prize annually. The award serves to promote research in the field of orthopaedic rheumatology. The prize is endowed with 7,000 euros.
View entry
News Icon

News categories: Honors & Funding

Acute lymphoblastic leukemia in children

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and poses a significant threat to health. The joint research project "EDI-4-ALL" (Early detection and interception for acute lymphoblastic leukemia) aims at the development of new analysis tools for the early detection of a genetic predisposition to ALL in newborns. The project is a joint endeavour by leading scientists from the Universities of Düsseldorf, Gießen and Bonn, the Charité Berlin and Zytovision, under participation of Prof. Alksandra Pandyra. The project is funded with a total of 2.6 million Euros by the BMBF.
View entry

Back to the news overview